Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Steve D. Paget"'
Autor:
Shao-Gang Li, Alexander L. Perryman, Alex Lemenze, Sean Ekins, Steve D. Paget, Pradeep Kumar, Xin Wang, Thomas P. Stratton, Joel S. Freundlich, Arthur J. Olson
Publikováno v:
ACS Infectious Diseases. 5:2148-2163
Tuberculosis, caused by Mycobacterium tuberculosis (M. tuberculosis), kills 1.6 million people annually. To bridge the gap between structure- and cell-based drug discovery strategies, we are pionee...
Autor:
Xin, Wang, Alexander L, Perryman, Shao-Gang, Li, Steve D, Paget, Thomas P, Stratton, Alex, Lemenze, Arthur J, Olson, Sean, Ekins, Pradeep, Kumar, Joel S, Freundlich
Publikováno v:
ACS Infect Dis
Tuberculosis, caused by Mycobacterium tuberculosis (M. tuberculosis), kills 1.6 million people annually. To bridge the gap between structure- and cell-based drug discovery strategies, we are pioneering a computer-aided discovery paradigm that merges
Autor:
Thomas P. Stratton, Patricia Soteropoulos, Joel S. Freundlich, Xin Wang, Hsin Pin Ho, Srinivasan Kandasamy, Seema Hussain, Alejandro Davila-Pagan, Ravindra Jadhav, Daigo Inoyama, Nisha Mittal, Eric Singleton, Sean Ekins, Véronique Dartois, Richard Pottorf, Yong Mo Ahn, Pradeep Kumar, Riccardo Russo, Joseph A. Bilotta, Matthew D. Zimmerman, Courtney Grady, Nancy D. Connell, Thomas J. Kim, Steve D. Paget, Steven Park, Shao-Gang Li
Publikováno v:
Cell Chem Biol
Summary The triazine antitubercular JSF-2019 was of interest due to its in vitro efficacy and the nitro group shared with the clinically relevant delamanid and pretomanid. JSF-2019 undergoes activation requiring F420H2 and one or more nitroreductases
Autor:
Steve D. Paget, Raul Goldschmidt, Barbara D. Foleno, Ellyn Wira, Robert K. Flamm, Karen Bush, Glenda C. Webb, Darren Abbanat, Mark J. Macielag
Publikováno v:
Antimicrobial Agents and Chemotherapy. 51:361-365
RWJ-416457, an investigational pyrrolopyrazolyl-substituted oxazolidinone, inhibited the growth of linezolid-susceptible staphylococci, enterococci, and streptococci at concentrations of ≤4 μg/ml, generally exhibiting two- to fourfold-greater pote
Autor:
Anne J. Lenaerts, Marilyn Ekonomidis, Mi Sun Koo, Hiyun Kim, Lisa K. Woolhiser, Steve D. Paget, Barry A. Bunin, Meliza Talaue, Sean Ekins, Robert C. Reynolds, Joel S. Freundlich, Nancy D. Connell
Publikováno v:
Chemistrybiology. 20(3)
Summary Identification of unique leads represents a significant challenge in drug discovery. This hurdle is magnified in neglected diseases such as tuberculosis. We have leveraged public high-throughput screening (HTS) data to experimentally validate